The marijuana producer is looking to restore consumer confidence after The Globe and Mail revealed in December that a recall of medical marijuana at Mettrum, a company now owned by Canopy, was due to the discovery of a banned pesticide
Canopy Growth Corp. to implement new pesticide-testing regime for cannabis
